🔎 Trials Near Me

Beranda › Kelebihan Berat Badan › Nevada › Las Vegas

Uji klinis Kelebihan Berat Badan di Las Vegas, NV

23 studi untuk Kelebihan Berat Badan mencari peserta di lokasi sekitar Las Vegas (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Menerima pesertaFase 2
  • Vector Clinical Trials /ID# 282265, Las Vegas
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07752979

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Menerima pesertaFase 3
  • Palm Research Center Inc., Las Vegas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07720271

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Menerima pesertaFase 3
  • M3 Wake Research - Las Vegas Cimarron, Las Vegas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07794579

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Menerima pesertaFase 3
  • Palm Research Center Tenaya, Las Vegas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Menerima pesertaFase 3
  • Excel Clinical Research, Las Vegas
  • Vector Clinical Trials, Las Vegas
Usia 45 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Menerima pesertaFase 3
  • AMR Clinical, Las Vegas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Menerima pesertaFase 2
  • Las Vegas Medical Research, Las Vegas
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Menerima pesertaFase 3
  • AURORA-1 Clinical Site, Las Vegas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Menerima pesertaFase 3
  • AURORA-2 Clinical Site, Las Vegas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743450

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Menerima pesertaFase 3Sukarelawan sehat diterima
  • ACCOMPLISH-2 Research Site, Las Vegas
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Menerima pesertaFase 3
  • Jubilee Clinical Research, Inc., Las Vegas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Menerima pesertaFase 2
  • Las Vegas Medical Research, Las Vegas
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Menerima pesertaFase 2
  • Vector Clinical Trials, Las Vegas
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07215559

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Menerima pesertaFase 3
  • Kailera Clinical Site, Las Vegas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Menerima pesertaFase 3
  • Palm Research Center Inc, Las Vegas
  • Vector Clinical Trials, Las Vegas
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Menerima pesertaFase 3
  • Kailera Clinical Site, Las Vegas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Menerima pesertaFase 3
  • Palm Research Center Inc, Las Vegas
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Menerima pesertaFase 3
  • Excel Clinical Research, Las Vegas
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07575399

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

Menerima pesertaSukarelawan sehat diterima
  • University of Nevada, Las Vegas, Las Vegas
Usia 21 hingga 74 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07566325

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Menerima pesertaFase 3
  • Research Site, Las Vegas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Menerima pesertaFase 3
  • ACCOMPLISH-1 Research Site, Las Vegas
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07654361

A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

Menerima pesertaFase 1
  • Corxel Investigational site, Las Vegas
Usia 18 hingga 55 · Wanita · Diperbarui 17 Jun 2026 · NCT07652047

Uji klinis Kelebihan Berat Badan di kota lain

Studi lain di Las Vegas

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.